C-反应蛋白检测在老年支气管哮喘与呼吸道感染中的应用研究

Application of C-reactive protein detection on senile bronchial asthma and respiratory tract infection in elderly patients

  • 摘要: 目的 观察C-反应蛋白(CRP)检测在老年支气管哮喘与呼吸道感染中的诊断价值, 为今后临床预防治疗提供参考依据。方法 选自2013年2月-2014年3月医院收治的老年支气管哮喘86例,分为哮喘合并细菌感染组45例,哮喘合并病毒感染组41例,另选同期进行健康体检44名健康者作为对照组,观察3组患者CRP和血细胞总数情况,数据采用SPSS 15.0软件进行统计分析。结果 细菌感染组患者C-反应蛋白水平、白细胞总数明显高于病毒感染组及对照组(P<0.05);细菌感染组C-反应蛋白异常率为93.3%,白细胞异常率为84.4%,明显高于病毒感染组的26.8%、12.2%,差异有统计学意义(P<0.05)。结论 血清C-反应蛋白可作为早期诊断哮喘合并感染的指标之一,其水平高低可反映病情的严重程度,有助于临床鉴别细菌与病毒感染,可为临床用药提供重要参考依据,具有较高应用价值。

     

    Abstract: OBJECTIVE To observe diagnostic value of C-reactive protein (CRP) detection in senile bronchial children and respiratory tract infection in elderly patients, so as to provide a reference basis for clinical prevention and treatment in the future. METHODS Eighty six elderly patients with senile bronchial asthma admitted and treated in the hospital from Feb. 2013 to Mar. 2014 were selected as research subjects, including 45 patients with asthma combined with bacterial infections, and 41 patients suffered from asthma combined with virus infections, and another 44 healthy persons undergoing health check-ups during the same period were selected as control group. The total numbers of blood cells of patients in the three groups were observed, and data were analyzed by SPSS 15.0. RESULTS C-reactive protein level and total number of white blood cells of patients in bacterial infection group were significantly higher than those of patients in virus infection group and control group (P<0.05). The abnormality rates of C-reactive protein and white blood cells of patients in bacterial infection group were 93.3% and 84.4%, significantly higher than 26.8% and 12.2% of patients in virus infection group (P<0.05). CONCLUSION The serum CRP may be used as one of indicators for early diagnosis of asthma combined with infection, its level may reflect the severity of the illness, contributing to clinical identification of bacteria and virus infection, and it may provide important reference basis for clinical medication, delivering higher application value.

     

/

返回文章
返回